1. Home
  2. FGI vs BGLC Comparison

FGI vs BGLC Comparison

Compare FGI & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FGI Industries Ltd.

FGI

FGI Industries Ltd.

HOLD

Current Price

$7.24

Market Cap

14.0M

Sector

Industrials

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$4.19

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FGI
BGLC
Founded
1987
2017
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
10.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
FGI
BGLC
Price
$7.24
$4.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.2K
205.0K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$135,654,095.00
$9,465,006.00
Revenue This Year
$3.80
N/A
Revenue Next Year
$6.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.66
2.21
52 Week Low
$2.28
$2.01
52 Week High
$12.62
$15.60

Technical Indicators

Market Signals
Indicator
FGI
BGLC
Relative Strength Index (RSI) 54.36 39.04
Support Level $5.51 $4.01
Resistance Level $7.36 $4.29
Average True Range (ATR) 1.36 0.19
MACD -0.06 0.02
Stochastic Oscillator 38.97 32.43

Price Performance

Historical Comparison
FGI
BGLC

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: